ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 331,58
0,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) Actualités

CYTK Cytokinetics Inc

52,50
0,22 (0,42%)
08 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cytokinetics Inc CYTK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,22 0,42% 52,50 06:00:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
52,10 50,87 52,935 52,79 52,28
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/6/202423:13EDGAR2Form 8-K - Current report
07/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202416:02EDGAR2Form 8-K - Current report
04/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:24EDGAR2Form 144 - Report of proposed sale of securities
04/6/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
03/6/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:36EDGAR2Form 144 - Report of proposed sale of securities
03/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:25EDGAR2Form 144 - Report of proposed sale of securities
03/6/202422:20EDGAR2Form 144 - Report of proposed sale of securities
03/6/202422:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/5/202422:00GLOBECytokinetics to Participate in June Investor Conferences
28/5/202422:01EDGAR2Form 8-K - Current report
28/5/202422:00GLOBECytokinetics Announces Closing of Public Offering of Common..
24/5/202422:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/5/202413:40IHMARKETNEWSOpenAI and News Corp Seal Partnership, DuPont de Nemours..
23/5/202405:30GLOBECytokinetics Announces Pricing of Public Offering of Common..
22/5/202422:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/5/202422:15EDGAR2Form 8-K - Current report
22/5/202422:13EDGAR2Form 8-K - Current report
22/5/202422:10GLOBERoyalty Pharma and Cytokinetics Announce Expanded Strategic..
22/5/202422:02GLOBECytokinetics Announces Proposed Public Offering of Common..
22/5/202422:00GLOBECytokinetics and Royalty Pharma Announce Expanded Strategic..
17/5/202413:30GLOBECytokinetics Hosts Muscle Biology-Focused Research..
17/5/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202413:30GLOBECytokinetics Announces Five Presentations Related to..
13/5/202422:09EDGAR2Form 8-K - Current report
13/5/202415:33GLOBECytokinetics Announces Primary Results From SEQUOIA-HCM..
10/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:05EDGAR2Form 8-K - Current report
08/5/202422:00GLOBECytokinetics Reports First Quarter 2024 Financial Results
08/5/202413:30GLOBECytokinetics Announces Topline Data From Phase 1 Clinical..
08/5/202413:05EDGAR2Form 8-K - Current report
08/5/202413:00EDGAR2Form 8-K - Current report
07/5/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:35EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:00GLOBECytokinetics to Hold Annual Meeting of Stockholders
02/5/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/4/202422:00GLOBECytokinetics to Host Investor Event and Conference Call to..
24/4/202422:00GLOBECytokinetics to Announce First Quarter Results on May 8,..
10/4/202413:30GLOBECytokinetics Announces Three Late Breaking Clinical Trial..
05/4/202413:30GLOBECytokinetics Presents Additional 48-Week Data From..

Dernières Valeurs Consultées

NASDAQ
CYTK
Cytokinetics
GATE
SPEXUSDT
StepEx
HITB
BSWUSDT
Biswap
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés